1. Home
  2. INVE vs MDXH Comparison

INVE vs MDXH Comparison

Compare INVE & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • MDXH
  • Stock Information
  • Founded
  • INVE 1990
  • MDXH 2003
  • Country
  • INVE United States
  • MDXH Belgium
  • Employees
  • INVE N/A
  • MDXH N/A
  • Industry
  • INVE Computer peripheral equipment
  • MDXH
  • Sector
  • INVE Technology
  • MDXH
  • Exchange
  • INVE Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • INVE 86.5M
  • MDXH 93.1M
  • IPO Year
  • INVE 1997
  • MDXH 2021
  • Fundamental
  • Price
  • INVE $3.48
  • MDXH $1.86
  • Analyst Decision
  • INVE Strong Buy
  • MDXH Strong Buy
  • Analyst Count
  • INVE 2
  • MDXH 2
  • Target Price
  • INVE $7.25
  • MDXH $7.00
  • AVG Volume (30 Days)
  • INVE 39.5K
  • MDXH 111.7K
  • Earning Date
  • INVE 03-11-2025
  • MDXH 02-26-2025
  • Dividend Yield
  • INVE N/A
  • MDXH N/A
  • EPS Growth
  • INVE N/A
  • MDXH N/A
  • EPS
  • INVE 3.10
  • MDXH N/A
  • Revenue
  • INVE $104,217,000.00
  • MDXH $84,708,000.00
  • Revenue This Year
  • INVE N/A
  • MDXH $28.76
  • Revenue Next Year
  • INVE N/A
  • MDXH $19.91
  • P/E Ratio
  • INVE $1.12
  • MDXH N/A
  • Revenue Growth
  • INVE 70.57
  • MDXH 33.01
  • 52 Week Low
  • INVE $2.95
  • MDXH $1.55
  • 52 Week High
  • INVE $9.24
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • INVE 43.25
  • MDXH 33.28
  • Support Level
  • INVE $3.50
  • MDXH $1.80
  • Resistance Level
  • INVE $3.82
  • MDXH $1.97
  • Average True Range (ATR)
  • INVE 0.18
  • MDXH 0.07
  • MACD
  • INVE -0.01
  • MDXH -0.01
  • Stochastic Oscillator
  • INVE 21.82
  • MDXH 12.50

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: